Zoltan Maliga, Ph.D. - US grants

Affiliations:

2004

Harvard University, Cambridge, MA, United States

Area:

Microtubules, Actin, Mitosis, Cell cycle

Tree Info Publications Similar researchers PubMed Report error

We are testing a new system for linking grants to scientists.

The funding information displayed below comes from the NIH Research Portfolio Online Reporting Tools and the NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please sign in and mark grants as correct or incorrect matches.

Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.

High-probability grants

According to our matching algorithm, Zoltan Maliga is the likely recipient of the following grants.

Years	Recipients	Code	Title / Keywords	Matching score
2020 — 2021	Maliga, Zoltan	R50Activity Code Description: The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to pursue research within the context of an existing research program, but not serve as Principal Investigators. The Award is intended to provide desirable salaries and sufficient autonomy so that individuals are not solely dependent on grants held by Principal Investigators for career continuity.	High Dimensional Digital Pathology to Investigate the Tumor Micro Environment and Its Impact On Response to Therapy @ Harvard Medical School Summary Grant: Research Specialist (PAR-19-291) Under the supervision of senior scientist Zoltan Maliga PhD, investigators and staff at the Harvard Medical School Laboratory of Systems Pharmacology (LSP) will contribute to cell and tissue imaging and analysis for U2C and U54 program grants LSP-based investigators will perform the tissue-based cyclic immunofluorescence (t-CyCIF) method developed at HMS on FFPE human and mouse skin samples provided by investigators and will work together to define and validate antibodies to stain biomarkers of skin development, inflammation, melanoma progression and tumor microenvironment and will share technologies under development to further advance the t-CyCIF method (e.g. switch to six-channel imaging, use of oligo-modified antibodies as detection reagents, combination of in situ hybridization or sequencing methods). The LSP will process t-CyCIF images, provide quantitative cell and tissue-level analysis and help distribute high-resolution multiplexed images as part of a disease pathology atlas. Maliga will work with PIs Lian, Murphy, LeBoeuf, Haigis, Aster to prepare manuscripts, write reports for the NIH and collaborate with other members of the project teams as required the by PAR-19-291. Show summary Hide summary	0.934